Among women with at least two affected first-degree relatives, risk of all the subtypes including TNBC and the predominant ER+ subtype, and ER−/PR−/HER2+ breast cancer was the most pronounced compared to women with no affected degree relatives [67]. This evidence concerns the gene ERBB2 and breast cancer.